Riyadh — Mubasher: Nahdi Medical Company’s board of directors convened on 7 October 2026 to appoint leadership and form specialized committees for a new four-year term.
The appointments follow the ordinary general assembly meeting held on 27 September 2026, which elected the board for a cycle that commenced on 5 October 2026, and concludes on 4 October 2030.
The board approved the appointment of Abdullah Amer Abdullah Al Nahdi, a non-executive member, as Chairman. Yasser Saleh Salem bin Mahfouz, also a non-executive member, was named Vice Chairman, while Fahad Ghazi Ahmed Alhaidari was appointed as Board Secretary.
The company also finalized the formation of several board committees. The Remuneration and Nominations Committee will be chaired by independent member Junaid Azmat Bajwa.
Additionally, a Digital Transformation and Cybersecurity Committee was established, with independent member Romain Pierre Voog serving as Chairman.
Nahdi Medical confirmed the appointment of its representatives to the Capital Market Authority (CMA) and the Saudi Tadawul to ensure compliance with ongoing regulatory requirements.
The company noted that the formation of the Audit Committee will be announced separately in a subsequent disclosure.
